Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics

被引:16
作者
Tan, Hui [1 ,4 ,5 ]
Zhang, Hongwei [2 ]
Yang, Weige [2 ]
Fu, Yipeng [2 ]
Gu, Yusen [1 ,4 ,5 ]
Du, Min [3 ]
Cheng, Dengfeng [1 ,4 ,5 ]
Shi, Hongcheng [1 ,4 ,5 ]
机构
[1] Fudan Univ, Dept Nucl Med, Zhongshan Hosp, Shanghai 200032, Peoples R China
[2] Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai, Peoples R China
[3] Fudan Univ, Dept Pathol, Zhongshan Hosp, Shanghai, Peoples R China
[4] Fudan Univ, Nucl Med Inst, Shanghai, Peoples R China
[5] Shanghai Inst Med Imaging, Shanghai, Peoples R China
关键词
biologic markers; breast cancer; breast-specific gamma imaging; clinicopathologic factors; sensitivity; Tc-99m-sestamibi; PROGNOSTIC-FACTORS; MAMMOGRAPHY; SURVIVAL; THERAPY; PATIENT; US;
D O I
10.1097/MNM.0000000000000518
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesTo determine the sensitivity of breast-specific gamma imaging (BSGI) in diagnosing breast cancer and assess the potential correlation between the semiquantitative index of BSGI and biologic markers, molecular subtypes, and clinicopathologic characteristics of breast cancer.Materials and methodsThe sensitivity of BSGI for breast cancer was retrospectively assessed in 102 female breast cancer patients who underwent BSGI before surgery and was compared with that of ultrasonography and mammography. BSGI was visually graded on the basis of the Society of Nuclear Medicine and Molecular Imaging guideline. Tracer uptake in the cancer as the lesion to nonlesion ratio (L/N) was calculated semiquantitatively and was subsequently correlated to tumor biologic markers, molecular subtypes, and clinicopathologic characteristics.ResultsThe sensitivity of BSGI for breast cancer by visual analysis was 94.1% (96/102) in our cohort, which was 100% (47/47) in the subgroup of patients with a tumor size more than 2.0cm and 89.1% (49/55) in the subgroup of patients with a size less than or equal to 2.0cm. The sensitivity of BSGI was significantly higher than that of ultrasonography of 84.2% (85/101) (P=0.022) and mammography of 84.5% (60/71) (P=0.037). There was no significant correlation between the L/N and expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and antigen Ki-67, and the subtypes or histologic grade of the cancer (P>0.05). However, the value of L/N was associated with infiltration degree (P=0.005), axillary lymph node status (P=0.029), and tumor size (P=0.002). Multivariate analysis further indicated that the value of L/N was correlated with infiltration degree (P=0.016) and tumor size (P=0.002).ConclusionBSGI has a high sensitivity for detecting primary breast cancer. The value of L/N on BSGI was independently related to infiltration degree and tumor size of breast cancer, but not to expression of tumor receptor markers and histologic grade.
引用
收藏
页码:792 / 799
页数:8
相关论文
共 29 条
  • [1] Azizun-Nisa, 2008, ASIAN PAC J CANCER P, V9, P553
  • [2] Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer
    Berg, WA
    Gutierrez, L
    NessAiver, MS
    Carter, WB
    Bhargavan, M
    Lewis, RS
    Ioffe, OB
    [J]. RADIOLOGY, 2004, 233 (03) : 830 - 849
  • [3] Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer
    Berg, Wendie A.
    Blume, Jeffrey D.
    Cormack, Jean B.
    Mendelson, Ellen B.
    Lehrer, Daniel
    Bohm-Velez, Marcela
    Pisano, Etta D.
    Jong, Roberta A.
    Evans, W. Phil
    Morton, Marilyn J.
    Mahoney, Mary C.
    Larsen, Linda Hovanessian
    Barr, Richard G.
    Farria, Dione M.
    Marques, Helga S.
    Boparai, Karan
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (18): : 2151 - 2163
  • [4] Bonazzi G, 2001, J EXP CLIN CANC RES, V20, P91
  • [5] Cwikla JB, 1999, ANTICANCER RES, V19, P2299
  • [6] Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010
    Garcia Fernandez, A.
    Gimenez, N.
    Fraile, M.
    Gonzalez, S.
    Chabrera, C.
    Torras, M.
    Gonzalez, C.
    Salas, A.
    Barco, I.
    Cirera, L.
    Cambra, M. J.
    Veloso, E.
    Pessarrodona, A.
    [J]. BREAST, 2012, 21 (03) : 366 - 373
  • [7] Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012
    Garcia Fernandez, Antonio
    Chabrera, Carol
    Garcia Font, Marc
    Fraile, Manel
    Gonzalez, Sonia
    Barco, Israel
    Gonzalez, Clarisa
    Cirera, Lluis
    Veloso, Enrique
    Maria Lain, Jose
    Pessarrodona, Antoni
    Gimenez, Nuria
    [J]. TUMOR BIOLOGY, 2013, 34 (04) : 2349 - 2355
  • [8] Molecular subtypes of breast cancer: metabolic correlation with 18F-FDG PET/CT
    Garcia Vicente, Ana Maria
    Soriano Castrejon, Angel
    Leon Martin, Alberto
    Chacon Lopez-Muniz, Ignacio
    Munoz Madero, Vicente
    Munoz Sanchez, Maria del Mar
    Palomar Munoz, Azahara
    Espinosa Aunion, Ruth
    Gonzalez Ageitos, Ana
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (09) : 1304 - 1311
  • [9] PET/CT and breast cancer subtypes
    Gilardi, Laura
    Colleoni, Marco
    Paganelli, Giovanni
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (09) : 1301 - 1303
  • [10] Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
    Goldhirsch, A.
    Wood, W. C.
    Coates, A. S.
    Gelber, R. D.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (08) : 1736 - 1747